Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00035945
Status:
COMPLETED
Last Update Posted:
2022-12-05
First Post:
2002-05-06
Brief Title:
ISIS 14803-CS2 Treatment With ISIS 14803 Administered IV in Patients With Chronic Hepatitis C Virus Infections
Sponsor:
Ionis Pharmaceuticals Inc
Organization:
Ionis Pharmaceuticals Inc
Organization Data
Organization:
Ionis Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
ISIS 14803-CS2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ionis Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Elan Pharmaceuticals | INDUSTRY |
| Hepasense | INDUSTRY |